| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/30/2008 | CN100364528C Compound amino acid vitamin dispersion tablet and its preparation method |
| 01/30/2008 | CN100364523C Simple production process for zinc citrate, zinc lactate, ferrous citrate and ferrous lactate |
| 01/30/2008 | CN100364522C Sustained releasing preparation of ferrosi succinas and its preparation method |
| 01/30/2008 | CN100364451C Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 01/30/2008 | CN100364423C Preparation method of fat-reducing blood sugar-reducing milk containing micro gingko leaf, Gymostamma pentaphyllum, haw and konnjaku powder |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323543 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
| 01/29/2008 | US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323478 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323441 Oral administration in a daily dosage of 150 to 750 mg per day in a form of tablets, capsules, granules, powder, or syrups |
| 01/29/2008 | US7323323 Harvesting the pancreas of piglets at or near full term gestation, and extracting pancreatic beta islet cells exposed to nicotinamide |
| 01/29/2008 | US7323165 Production of pancreatic islet cells and delivery of insulin |
| 01/29/2008 | CA2477538C Chimeric pancreas |
| 01/29/2008 | CA2451851C Use of pigment such as e.g. titanium dioxide for obtaining a special optical effect on oral medicament or food |
| 01/29/2008 | CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids |
| 01/29/2008 | CA2326148C Method for providing glutamine |
| 01/29/2008 | CA2315696C Pharmaceutical composition for oral administration |
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2284668C High beta-conglycinin products and their use |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/29/2008 | CA2207078C Insulin derivatives with increased zinc binding |
| 01/24/2008 | WO2008011562A2 Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 01/24/2008 | WO2008011499A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 01/24/2008 | WO2008011364A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011363A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 01/24/2008 | WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010472A1 Total enteral nutrition composition |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010238A2 Antidiabetic azabicyclo [3. 1. 0] hexan compounds |
| 01/24/2008 | WO2008009954A1 Medical use of cyclin dependent kinases inhibitors |
| 01/24/2008 | WO2008009813A2 Use of an extract of gleditsia in cosmetics and in dermatology |
| 01/24/2008 | WO2008009335A2 Aminoindazole urea derivatives |
| 01/24/2008 | WO2008009125A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 01/24/2008 | WO2007139948A3 Imidazoazepinone compounds |
| 01/24/2008 | WO2007137417B1 Heterocyclic compounds as calcium channel blockers |
| 01/24/2008 | WO2007137103A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/24/2008 | WO2007131907A3 1h-indol-5-yl-piperazin-1-yl-methanone derivatives |
| 01/24/2008 | WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | WO2007051811A3 Pharmaceutical use of substituted amides |
| 01/24/2008 | WO2007051810A3 Pharmaceutical use of substituted amides |
| 01/24/2008 | WO2007007042A8 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/24/2008 | WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists |
| 01/24/2008 | WO2006107902A8 Use of spirostenols to treat mitochondrial disorders |
| 01/24/2008 | WO2006029371A3 Neuromedin u 2 receptor agonists and uses thereof |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021418 Lipolysis stimulator |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021106 Cellular uptake of bioactive agents |
| 01/24/2008 | US20080021092 Stable pharmaceutical compositions of orlistat |
| 01/24/2008 | US20080021091 Crystalline duloxetine hydrochloride |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021086 Administering mitglinide or mitglinide calcium hydrate; hypertriglyceridemia; hypercholesterolemia; hyperlipidemia; anticholesteraol agents; antidiabetic agents; glucose intolerance; non-insulin dependendent diabetes; side effect reduction; cardiovascular disorders |
| 01/24/2008 | US20080021070 Pyridine derivatives, preparation and therapeutic application thereof |
| 01/24/2008 | US20080021052 Novel glucokinase activators and methods of using same |
| 01/24/2008 | US20080021049 Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related Compounds |
| 01/24/2008 | US20080021032 Pyrazole glucokinase activators |
| 01/24/2008 | US20080021031 Selenophene compounds |
| 01/24/2008 | US20080021030 Substituted Pyrazoles As Ppar Agonists |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021024 Metalloprotease inhibitors |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021015 Use as medicine of a compound restoring active principles in vivo |
| 01/24/2008 | US20080021009 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/24/2008 | US20080020995 Use of Cyclodextrin Complexes Containing Lipoic Acid |
| 01/24/2008 | US20080020977 Use of Fullerenes to Oxidize Reduced Redox Proteins |
| 01/24/2008 | US20080020974 Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x |
| 01/24/2008 | US20080020972 Use of human chorionic gonadotropin orally for the treatment of overweight (obesity) associated with high blood tension, non-insulin-dependent diabetes, hypercholesterolemia, dyslipidemias and lipodystrophy |
| 01/24/2008 | US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 01/24/2008 | US20080020069 Beverage precursor and process for the manufacture thereof |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080020019 Method of decreasing fat deposits and body weight in mammals and birds |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080019997 Therapeutic uses of dunaliella powder |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019950 Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | US20080019911 Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 |
| 01/24/2008 | DE102007032613A1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof |
| 01/24/2008 | DE102006033140A1 Aminoindazolharnstoffderivate Aminoindazolharnstoffderivate |
| 01/24/2008 | CA2692440A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 01/24/2008 | CA2659155A1 Substituted azole aromatic heterocycles as inhibitors of 11.beta.-hsd-1 |